Information Journal Paper
APA:
CopyMEI, H.E., & SCHMIDT, S.. (2012). RATIONALE OF ANTI-CD19 IMMUNOTHERAPY: AN OPTION TO TARGET AUTOREACTIVE PLASMA CELLS IN AUTOIMMUNITY. ARTHRITIS RESEARCH AND THERAPY, 14(SUPPL 5), 0-0. SID. https://sid.ir/paper/673005/en
Vancouver:
CopyMEI H.E., SCHMIDT S.. RATIONALE OF ANTI-CD19 IMMUNOTHERAPY: AN OPTION TO TARGET AUTOREACTIVE PLASMA CELLS IN AUTOIMMUNITY. ARTHRITIS RESEARCH AND THERAPY[Internet]. 2012;14(SUPPL 5):0-0. Available from: https://sid.ir/paper/673005/en
IEEE:
CopyH.E. MEI, and S. SCHMIDT, “RATIONALE OF ANTI-CD19 IMMUNOTHERAPY: AN OPTION TO TARGET AUTOREACTIVE PLASMA CELLS IN AUTOIMMUNITY,” ARTHRITIS RESEARCH AND THERAPY, vol. 14, no. SUPPL 5, pp. 0–0, 2012, [Online]. Available: https://sid.ir/paper/673005/en